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Background: Dysfunction of the 5-hydroxytryptamine (5-HT) signaling pathway can lead to gastrointestinal motility
and secretion abnormalities and to visceral hypersensitivity. The aim of this study is to investigate the role of 5-HT
in reflux-induced esophageal mucosal injury.
Methods: Fifty 8-week-old male Sprague-Dawley (SD) rats were randomly divided into a gastroesophageal reflux
(GER) model group (30 rats) and a sham surgery control group (20 rats). Four weeks after surgery, the esophageal
mucosa was collected for histological evaluation, 5-HT concentrations, and 5-HT selective reuptake transporter
(SERT) mRNA and 5-HT4 receptor (5-HT4R) protein expressions.
Results: Twenty-seven rats in the GER model group survived, and three rats died. Histologically, in the GER model
group, 20 rats had reflux esophagitis (RE group), and 7 rats had non-erosive reflux disease (NERD group). The 5-HT
levels in the esophageal tissue from the RE group were significantly higher than those from the control and NERD
groups. Both the RE and NERD groups showed significant increases in SERT mRNA expression of the esophageal
mucosa than that of the controls, and the SERT mRNA level in the RE group was significantly higher than that in
the NERD group. The 5-HT4R protein level of the esophageal mucosa in the RE group was significantly lower than
that in the controls and the NERD group.
Conclusions: We conclude that a 5-HT signaling pathway disorder could be a major factor in the pathogenesis of
GER and RE.
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Gastroesophageal reflux (GER) is defined as the reflux of
the gastric contents into the esophagus or oropharyngeal
area. The main etiological factors related to GER are
lower esophageal sphincter (LES) dysfunction, decreased
esophageal clearance capacity, esophageal mucosal bar-
rier dysfunction, and esophageal visceral hypersensitivity
[1,2]. If acidic and non-acidic substances cannot be effect-
ively removed from the esophagus, reflux can lead to
esophageal mucosal damage, causing reflux esophagitis
(RE) and other complications, such as esophageal mucosal* Correspondence: mizu@zju.edu.cn
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reproduction in any medium, provided the orbleeding, esophageal stricture, and dysphagia. The scaven-
ging capacity of the esophageal mucosa depends on
esophageal motor function, which may play an important
role in reflux-induced esophageal mucosal injury. Normal
esophageal motility depends on the coordination of esopha-
geal smooth muscle contraction and relaxation, which is
the physiological basis of the normal reaction of esopha-
geal smooth muscle to different neurotransmitters. Some
studies have reported that RE is associated with impaired
esophageal smooth muscle reactivity, which is a key factor
in esophageal motility disorders [3,4].
It has been found that 5-hydroxytryptamine (5-HT,
serotonin) signaling dysfunction can lead to gastrointes-
tinal motility and secretion abnormalities and to visceral
hypersensitivity [5,6]. 5-HT is a derivative of tryptophan
and is the major precursor of 5-hydroxyindole aceticd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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synthesized in enterochromaffin cells (ECs), which
utilize tryptophan hydroxylase-1 (TPH-1) as their rate-
limiting enzyme in the biosynthesis of 5-HT. 5-HT is
released locally and acts on specific receptors located on
nearby nerve fibers and cells in the lamina propria. The
actions of 5-HT are terminated by 5-HT selective re-
uptake transporters (SERTs), which remove 5-HT from
the interstitial space. Today, a total of 14 types of 5-HT
receptors (5-HTRs) have been discovered. 5-HT4 recep-
tors (5-HT4R) have been confirmed in human and animal
esophageal tissues. The binding of 5-HT and 5-HT4R may
activate adenylyl cyclase (AC), which increases the con-
centration of cyclic adenosine monophosphate (cAMP),
thereby activating cAMP-dependent protein kinase A
(PKA) and causing the hyperpolarization of smooth
muscle cells and the reduction of Ca2+ influx, resulting in
smooth muscle relaxation [7]. Esophageal smooth muscle
relaxations play an important role in the maintenance of
normal esophageal motility. Therefore, we speculated that
the 5-HT signaling pathway might be involved in the regu-
lation of esophageal motility in reflux-induced esophageal
mucosal injury.
This study was undertaken by establishing a rat model
of GER (as part of cardiac angioplasty), which has been
shown to reflect natural GER better [8]. Esophageal pH
was measured to evaluate the degree of reflux. Esophageal
mucosal injury was assessed by gross findings and histo-
pathological methods. 5-HT content and the SERT mRNA
and 5-HT4R protein levels of esophageal tissue from rats
were studied to evaluate the role of the 5-HT signaling
pathway in reflux-induced esophageal mucosal injury.
Materials and methods
Reagents and animals
The following materials were used: 5-HT standard (Sigma,
USA); polyclonal rabbit 5-HT4R antibody and monoclonal
rabbit GAPDH antibody (Abcam, USA); HRP conjugated
goat anti-rabbit secondary antibody (Zymed, USA); a
SYBR PrimeScript RT-PCR kit (TaKaRa Corp., Japan); and
primers for SERT and GAPDH, synthesized by Shanghai
Biological Engineering Co., Ltd. (Shangon, China). Eight-
week-old male SD rats were purchased from the Experi-
mental Animal Center of Zhejiang University. All animal
experiments of this study were approved by the Animal
Care Committee of Zhejiang University.
Methods
Establishment of GER animal model
SD rats in the GER model group underwent preoperative
fasting for 24 h, and no water was permitted on the mor-
ning of the day of surgery. The rats were anesthetized by
an intraperitoneal injection method of 1% pentobarbital
(35 mg/kg). A partial cardioplasty was performed by alongitudinal incision through the gastric cardiac muscle
with reference to Erbil Y (similar to Heinecke-Mikulicz
pyloroplasty) [8]. After surgery, the rats fasted for a further
48 h with free access of water. The rats that underwent
sham operations served as the control group.
Postoperative observation, determination of lower
esophageal pH, and sample preparation
Following surgery, the feeding, activity, and weight
change of each rat were closely observed every day. Four
weeks post operation, lower esophageal pH was mea-
sured using a Digitrapper MKIII pH monitor (Synectics
Medical, USA). The rat was anesthetized with an intra-
peritoneal injection of 1% pentobarbital (35 mg/kg). Its
abdominal cavity was opened to expose the stomach and
lower esophagus. Through a small hole/incision made at
the greater curvature of the stomach, a pH catheter was
inserted retrograde and positioned 1.5 cm above the gas-
troesophageal transition zone to record esophageal pH.
The rats were killed, the gross findings of the esophageal
mucosa were observed, and distal esophageal tissue sam-
ples were collected in several longitudinal sections. One
section was fixed with 10% formaldehyde, and the others
were stored at -80°C for biochemical and other studies.
After creating 4-μm-thick paraffin sections, hematoxylin
and eosin (HE) staining was performed for histological
evaluation under an optical microscope. Reflux esopha-
gitis (RE) was diagnosed when esophageal microscopic
inflammation was observed, including basal layer thick-
ening, vascular congestion, and eosinophil infiltration.
Measurement of 5-HT concentrations in esophageal tissue
by HPLC-ECD
Esophageal tissue was homogenized at a 1:10 weight
ratio with 0.2 M perchloric acid on ice. After being cen-
trifuged at 13,000 r/min for 30 min, the supernatant was
collected and filtered with a 0.22-μm 3000D membrane
(Millipore, USA) and then centrifuged at 12,000 r/min
for 40 min at 4°C. The samples were then diluted two
fold with 0.2 M perchloric acid and were subjected to
HPLC-ECD analysis (ESA System, USA) on an ESA
MD150-type C18 analytical column (3 mm × 150 mm,
3 μm) under the following conditions: electrode voltage
E1 = -150 mV, E2 = 200 mV, and protective electrode
voltage EGC = 350 mV. The concentrations of 5-HT in
the esophageal tissue were calculated using the 5-HT
standard curve.
SERT mRNA levels detected by real-time RT-PCR
An esophageal sample of approximately 30 mg was
ground into powder in a mortar using liquid nitrogen,
and total RNA was extracted using the isopropanol
method. cDNA was synthesized in a 10-μl system
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mescriptTM RT enzyme mix I, 0.5 μl of 50 μM Oligo(dT)
primer, 0.5 μl of 100 μM Random 6-mer, and 2 μl total
RNA at 37°C for 15 min. The product was incubated at
85°C for 5 s and was stored at -20°C. The mRNA levels of
SERT and GAPDH were detected by real-time PCR using
a 7900 real-time PCR instrument (ABI, USA). The primers
for SERT (forward: 5’-GATTTCCTCCTGTCCGTCATT-
3’; reverse: 5’TCGGGCAGATCTTCCTCCAT-3’) and for
GAPDH [forward: 5’-GACAACTTTGGCATCGTGGA-
3’; reverse 5’-ATGCAGGGATGATGTTCTGG-3’, designed
by Shanghai Biological Engineering Co., Ltd. (Shangon,
China)] were used. The product sizes were 211 bp and
133 bp for SERT and GAPDH, respectively. The 10-μl-
total reaction system contained 5 μl of 2× SYBRR Premix
Ex TaqTM, 0.4 μl of 10 μM PCR forward primer, 0.4 μl of
10 μM PCR reverse primer, 0.2 μl of 50× Rox reference
dye and 1 μl of two-fold diluted cDNA template under
the following conditions: 10 s at 95°C, followed by 40
cycles of 5 s at 95°C and 30 s at 60°C. Real-time PCR for
each sample was performed in triplicate. The relative
mRNA levels of the target genes to control GAPDH were
calculated by ΔCt. PCR products were further examined
by 1.8% agarose gel electrophoresis and were photo-
graphed using Gel Doc1000 image analysis systems (Bio-
Rad, USA).Figure 1 Gross findings of esophageal mucosa in GER rat (A)
and sham-operated controls (B). Normal macroscopic esophageal
mucosa is shown in A. The presence of gross inflammation is shown
in B, such as esophageal mucosal congestion or erosion.5-HT4R protein expression detected by Western blot method
Roughly 30 mg of esophageal tissue was mixed with 100
μl/10 mg lysis buffer containing fresh PMSF, and the
mixture was homogenized on ice. The supernatant was
collected after centrifugation at 12,000 r/min for 5 min.
The protein concentration was determined using the
BCA method with a SmartSpecTM protein and a nucleic
acid analyzer (Bio-Rad, USA).
Protein samples of 12.5 μg were mixed with 5× sample
buffer, boiled for 10 min at 95°C, and cooled on ice.
After centrifugation at 12,000 r/min, the samples were
subjected to SDS-PAGE and were transferred onto
PVDF membrane. The membrane was then blocked with
5% BSA and was incubated with rabbit polyclonal
5-HT4R antibody (1:500 dilutions) for approximately
20 h on ice with oscillation. After being washed three
times with TBST, the membrane was incubated with
fluorescent-labeled anti-rabbit IgG at 1:5,000 dilutions
at room temperature for 1 h in the dark under agitation.
The band was visualized using an Odyssey dual-infrared
laser system (800 nm channel, fluorescent value of 7.0).
The GAPDH level was similarly detected using a rabbit
monoclonal antibody (1:2,000) and the same system (800
nm channel, fluorescent value of 5.0). The images were
quantitatively analyzed by converting the signals into gray-
scale data using Quantity One grayscale software.Statistical analysis
The results are expressed as the means ± standard devia-
tions. All of the statistical analyses were performed with
statistical software (SPSS, version 16.0). Student’s t-test
or one-way ANOVA with an LSD test was used where
appropriate. Significance was expressed at the P < 0.05
level.
Results
Lower esophageal pH value
Four weeks after the operation for GER, the lower
esophageal pH was significantly lower in GER model
group than that in controls (5.0 ± 0.28 vs. 6.4 ± 0.3, t =
3.757, P < 0.001).
Three out of 30 (10%) rats in the GER model group
died after surgery, while none of 20 rats in the control
group died. As shown in Figure 1, most of the rats in
the GER model group had esophageal mucosal conges-
tion or erosion on gross examination, while there were
no visible changes in controls.
Histological assessment of the esophageal mucosa
Twenty out of 27 (74%) rats in the GER model group
had reflux esophagitis (RE group), including basal layer
Figure 2 Histological assessment of the esophageal mucosa
(hematoxylin and eosin ×200) from sham operated rats (A) and
GER model rats (B, C). Normal esophageal mucosa is shown in A
(controls). The absence of esophageal mucosal inflammation is
shown in B (NERD). Basal layer thickening, vascular congestion, and
infiltration of inflammatory cells, such as eosinophils, are shown in C
(reflux esophagitis, RE).
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(HE ×200), while the remaining 7 rats had non-erosive re-
flux disease (NERD group). None of the 20 rats in the
control group had inflammation or other pathological
changes, as shown in Figure 2A-C.
5-HT content in esophageal tissue
As shown in Figure 3, 5-HT levels were significantly
higher in the esophageal tissue of the rats with RE than
those in either the NERD or control group (P < 0.05).
The relative expression of SERT mRNA in esophageal
tissue
As shown in Figure 4, the relative expressions of SERT
mRNA (Δct) in both the RE group and NE group were
significantly higher than that of the controls (P < 0.01).
The SERT transcript level in the RE group was also signifi-
cantly higher than that in the NERD group (P < 0.01).
The protein expression of 5-HT4R in esophageal tissue
As shown in Figure 5, the protein expression of 5-HT4R
in the RE group was significantly lower than that in ei-
ther the NERD or control group (P < 0.01).
Discussion
In addition to vomiting, GER is closely related to
chronic cough, refractory asthma, recurrent pneumonia,
malnutrition, and sudden infant death syndrome. How-
ever, its pathogenic mechanism is not fully understood
[1,2]. Animal models are commonly used to investigate
its underlying pathogenesis. In this study, we first estab-
lished a GER model rat with reference to Erbil Y [8].
Our results showed that the GER model group had sig-
nificantly lower esophageal pH than the sham-operated
control group and that RE occurred in 74.1% (20/27) in
the GER model group and in 0% in the control group,
indicating that GER and RE models were successfully
established.
In general, acid reflux is thought to be one of the major
factors causing esophageal mucosal injury. The severity of
mucosal injury depends on the nature of reflux sub-
stances, clearance ability of the esophageal mucosa, and
the resistance or sensitivity of the mucosal epithelium.
The clearance ability of esophageal mucosa is regulated by
esophageal motor function, i.e., coordination of esophageal
smooth muscle contraction and relaxation. It has been
suggested that esophageal inflammation may be associated
with esophageal motility disorder. It was reported that
neurotransmitters regulating gastrointestinal motility, se-
cretion, and sensation play an important role in the RE
pathogenesis. Rats with esophageal reflux have decreased
smooth muscle contractile responses to carbachol (recep-
tor mediated) and KCl (non-receptor mediated), as well as
decreased relaxation to 5-HT (receptor mediated) [9].In this study, we found that the 5-HT concentrations
in esophageal tissue were significantly higher in the RE
group than in the controls, while the levels in the NERD
group were not higher than in the controls, indicating
Figure 3 Serotonin (5-HT) content (ng/ml) in the esophageal
tissue of rats with reflux esophagitis (RE) and in NERD rats.
5-HT levels were significantly higher in the esophageal tissue of rats
with RE compared to controls (*P < 0.05). 5-HT content was
significantly lower in the esophageal tissue of NERD rats than those
with RE (#P < 0.05).
Figure 5 The protein expression of 5-HT4R in the esophageal
tissue in rats with RE and in NERD rats as detected by Western
blots. Representative Western blots of 5-HT4R in each group are
shown at the top, with GAPDH expression used as a control (A). The
results are expressed the ratio of 5-HT4R to GAPDH for immunoblots.
Note that 5-HT4R expression is significantly downregulated in RE rats
compared to NERD rats and controls. *P < 0.01 (B).
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5-HT is mainly synthesized in enterochromaffin cells
through tryptophan metabolism. Synthesized 5-HT is
stored as secretory granules in the basal membrane of
secretory cells, functioning as paracrine molecules. Se-
cretion of 5-HT is affected by many factors, such as local
metabolites, hypertonic solution, chemical stimulation,
and cell injury [10]. The increased 5-HT levels in the RE
group were possibly due to acid stimulation of the
esophageal mucosa. In addition, the injured esophageal
mucosa perhaps further promotes 5-HT release. Released
5-HT is rapidly transported by SERT and is taken up again
by adjacent cells in which 5-HT is further oxidized by
monoamine oxidase into 5-HIAA and is metabolized after
binding to UDP-glucuronide. Our results indicate that
SERT mRNA levels in both the RE and NERD groupsFigure 4 Relative expression of serotonin reuptake transporter
(SERT) mRNA levels in the esophageal tissue of rats with reflux
esophagitis (RE) and NERD rats. The results are expressed as Δct.
A significantly higher level of SERT mRNA was detected in samples
from both RE rats and NERD rats compared to controls (*P < 0.01),
while SERT transcript levels were significantly increased in the
esophageal tissue of rats with RE compared to NERD rats (#P < 0.01).were significantly higher than in the controls. The SERT
mRNA level in the RE group was also significantly higher
than in the NERD group, suggesting that the generation of
esophagitis is related to an increased SERT level. SERT
can quickly transport 5-HT from cell gaps into cells,
where it is inactivated, leading to decreases in esophageal
peristaltic function and reflux clearance ability.
The biological function of 5-HT is exerted by binding
to its specific receptor, 5-HTR. Based on the pharmaco-
logical parameters, cDNA sequence, and signal transduc-
tion mechanisms, 5-HTRs are divided into seven
categories: 5-HT1A-E, 5-HT2A-C, 5-HT3, 5-HT4, 5-HT5,
5-HT6, and 5-HT7. Among these categories, 5-HT1A, 5-
HT1B, 5-HT1P, 5-HT2A, 5-HT2B, 5-HT3, 5-HT4, and 5-
HT7 are expressed in the gastrointestinal tract. 5-HT4R
has been shown to exist in the esophageal tissues of both
humans and animals [11,12]. Furthermore, activation of
5-HT4R can increase LES tension and promote esopha-
geal submucosal gland (SMG) secretion [9,13]. We
found that protein expression of 5-HT4R was signifi-
cantly decreased in the RE group compared to both the
NERD and control groups. 5-HT4R agonists, such as
gastrointestinal prokinetic drugs, can promote gastro-
intestinal motility, accelerate clearance of reflux sub-
strates, and reduce reflux symptoms [14]. Many 5-HT4R
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serod, a partial 5-HT4R agonist, can safely and effectively
reduce postprandial esophageal acid exposure by enhan-
cing the esophageal acid clearance capacity, accelerating
gastric emptying, and reducing the occurrence of transit
lower esophageal sphincter relaxation (TLESR) [15], pro-
moting bicarbonate and mucus secretion from the SMGs
[13] and adjusting visceral sensitivity, thus reducing re-
flux, lowering the pain threshold of the esophagus to
mechanical expansion, improving esophageal peristalsis,
and reducing functional heartburn symptoms [14,16,17].
Another 5-HT4R agonist, renzapride, can promote
acetylcholine (Ach) release from parasympathetic axons,
increasing LES contraction and LES tension [9]. Cisa-
pride, another 5-HT4R agonist, can increase LES tension
and esophageal peristalsis, promoting gastric emptying,
reducing the contact of gastric acid and non-acid reflux
substances with the esophageal mucosa and decreasing
reflux symptoms [14]. Decreased 5-HT4R expression, to-
gether with increased SERT expression, synergistically
weakens 5-HT receptor-mediated signaling, thereby pro-
moting GER occurrence and leading to esophageal muco-
sal damage. It was also reported that the SERT inhibitor
citalopram can reduce esophageal sensitivity to chemical
and mechanical stimuli [18].
A potential limitation of the study is related to the
relatively small sample size, which did not allow us to
identify the concentration of 5-HT in varying degrees of
esophageal mucosal injury. Another limitation is that
esophageal smooth muscle peristalsis in the RE group
has not been detected. Therefore, further studies are
needed to substantiate these findings.Conclusion
In conclusion, acid reflux may stimulate the secretion of
5-HT in the esophageal mucosa. A significant increase in
SERT expression and a reduction in 5-H4R expression will
weaken the effects of 5-HT on its effector cells, resulting
in decreased post-contractional relaxation of esophageal
smooth muscle, impaired coordination of contraction and
relaxation, and decreased clearance of refluxed substances,
subsequently causing esophageal mucosal damage and
esophagitis. The results of our study suggest that the 5-
HT signaling pathway plays an important role in the
pathogenesis of GER.Abbreviations
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